Advansix Inc. 10-Q Summary: Q2 2026
Business Context and Reporting Period
Advansix Inc. (ASIX) is a vertically integrated chemistry company producing nylon solutions, plant nutrients, and chemical intermediates from five U.S.-based facilities. This report covers the quarterly period ended June 30, 2026. The company operates as a single reportable segment. Actual closing dates for the period were July 4, 2026, resulting in six additional reporting days compared to the prior year.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | Q2 2025 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Sales | $421.3 million | $410.0 million | $825.5 million | $787.8 million |
| Net Income (Loss) | $3.2 million | $31.4 million | ($12.3) million | $54.7 million |
| Diluted EPS | $0.12 | $1.15 | ($0.46) | $2.01 |
| Gross Margin % | 7.4% | 14.3% | 4.2% | 14.2% |
| Operating Cash Flow (YTD) | ($5.3) million | $32.6 million | ($5.3) million | $32.6 million |
| Cash & Equivalents | $7.2 million | $19.8 million (Dec 2025) | $7.2 million | $19.8 million (Dec 2025) |
| Debt (Line of Credit) | $275.0 million | $215.0 million (Dec 2025) | $275.0 million | $215.0 million (Dec 2025) |
Material Changes vs. Prior Period
- Profitability Decline: Net income dropped significantly year-over-year, turning from a $31.4 million profit in Q2 2025 to a $3.2 million profit in Q2 2026. Year-to-date, the company reported a net loss of $12.3 million compared to $54.7 million in profit the prior year.
- Margin Compression: Gross margin percentage contracted sharply to 7.4% in Q2 2026 from 14.3% in Q2 2025. This was driven by increased raw material costs (benzene, sulfur, propylene) and lower production rates due to plant turnarounds.
- Volume vs. Price: Sales increased 2.7% in Q2 2026, driven by favorable pricing (17.5% increase) which offset a 14.8% decline in volume. The volume decline was primarily due to reduced in-season Plant Nutrients sales.
- Cash Flow: Operating cash flow turned negative at ($5.3) million for the six months ended June 30, 2026, compared to $32.6 million in the prior year, largely due to the decrease in net income.
- Debt Utilization: The company increased borrowings under its revolving credit facility by $60 million during the first half of 2026, bringing the balance to $275 million.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects total capital expenditures for 2026 to be between $75 million and $95 million, down from $116 million in 2025, reflecting a prioritization of base investments.
- Liquidity: As of June 30, 2026, the company held $7.2 million in cash with approximately $224 million of additional capacity available under its $500 million revolving credit facility. The company remains in compliance with all financial covenants.
- Dividends: The Board declared a quarterly cash dividend of $0.16 per share, payable September 1, 2026.
- Share Repurchases: No shares were repurchased under the authorized program since June 2024. Approximately $62.0 million remains available under the current authorization.
- Goodwill Assessment: Due to a sustained decline in market capitalization, the company performed a quantitative goodwill impairment assessment in Q2 2026. The assessment concluded that the fair value of the reporting unit exceeded its carrying value, resulting in no impairment.
- Risks: Key risks include volatility in raw material prices (cumene, natural gas, sulfur), geopolitical conflicts impacting supply chains, and the cyclical nature of the industries served. The company noted that changes in forecasted earnings impacted the effective tax rate.
Investor Verification Checklist
- Margin Sustainability: Verify the trajectory of gross margins given the 10% year-over-year decline and the sensitivity to raw material pass-through pricing.
- Working Capital Trends: Monitor the significant increase in accounts receivable ($187.4 million vs. $154.1 million at year-end) and the drawdown of cash reserves.
- Debt Covenants: Confirm continued compliance with the Consolidated Leverage Ratio (max 3.75:1) and Interest Coverage Ratio (min 3.00:1) as operating income fluctuates.
- Plant Nutrients Seasonality: Assess the impact of reduced grower application on future quarters, as this segment drives a significant portion of volume.
- Goodwill Valuation: Review the assumptions used in the Q2 2026 goodwill impairment test, particularly regarding future cash flow projections and discount rates, given the recent market cap decline.